GET DAILY SIGNALSHenry Schein (HSIC) vs NiSource (NI): Distribution Momentum Meets Utility Stability
Key Takeaways
- Henry Schein (HSIC) is a global distributor of dental and medical supplies, while NiSource (NI) is a regulated natural gas and electric utility — two fundamentally different business models, growth drivers, and risk profiles.
- HSIC has shown stronger relative price momentum over the past year, while NI has lagged the broader market despite a compelling long-term data center growth story.
- HSIC carries a broad "Buy" analyst consensus with meaningful upside to average price targets, whereas NI's outlook hinges on execution of a $40 billion capital plan and regulatory approvals.
- Tickeron AI Verdict: HSIC — based on stronger trend consistency, improving earnings momentum, and more favorable near-term positioning relative to NI.
- For deeper insight, explore HSIC Major News and HSIC Today's Price Move, as well as NI Major News and NI Today's Price Move.
- Interested in automated, data-driven signals? Discover the Trending AI Robots curated by Tickeron for current market conditions.
Setting the Stage
This stock comparison examines two companies that rarely appear side by side: HSIC, the world's largest provider of healthcare solutions to office-based dental and medical practitioners, and NI, a regulated utility serving roughly four million natural gas and electric customers across six states. They occupy different sectors — healthcare distribution versus utilities — yet both are mid-to-large-cap names facing meaningful catalysts. Traders evaluating relative momentum and investors weighing growth against stability may find this comparison useful. Understanding how each company is positioned across business model, momentum, and risk can clarify which profile better fits current market conditions. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in their respective industries.
HSIC Overview and Recent Performance
Henry Schein, Inc. (HSIC) distributes dental and medical products, equipment, technology, and value-added services to practitioners worldwide. Recent market activity reflects renewed optimism around the company's execution. In recent quarters, the firm reported sales growth of roughly 6.7% and raised its full-year sales growth guidance to a range of 4.5% to 5.5%, supported by stable dental demand and market-share gains. Management has outlined a program targeting at least $200 million in operating income improvement, alongside a leaner cost structure. A leadership transition, including a new chief financial officer, and new technology distribution partnerships have added to the narrative. Shares have advanced roughly 15% year to date, with a one-year total return near 36%, and most analysts maintain a "Buy" rating with an average price target above the prevailing price.
NI Overview and Recent Performance
NiSource Inc. (NI) operates regulated natural gas and electric utilities, including NIPSCO in Indiana and Columbia Gas across several states. Recent performance has been steady but comparatively muted: shares have added only about 4% year to date, underperforming the broader market. The company's third-quarter report showed adjusted earnings per share of $0.27, beating consensus, though revenue fell slightly short of estimates. NI has extended its capital plan through 2033 to roughly $40 billion and raised its long-term adjusted earnings growth outlook, anchored by a fast-growing GenCo (generation company) segment serving data centers. A 20-year electricity agreement with Microsoft, alongside deals with Amazon and Alphabet, underpins this strategy. Offsetting tailwinds are elevated financing needs, planned equity issuance, and cost pressures from a severe August storm in Indiana. From what I see, the data center angle is worth monitoring closely over the longer term.
Head-to-Head Comparison
The core contrast between these two stocks is cyclical growth versus regulated stability. HSIC is a healthcare distribution business with a lower beta (about 0.84), cyclical exposure to dental and medical procedure volumes, and a restructuring-driven margin story. Its growth is tied to organic volume, private-label penetration, and disciplined acquisition activity. NI, by contrast, is a capital-intensive utility offering a forward dividend yield near 2.7% and earnings visibility from regulated rate recovery, but it faces financing risk from its expanded capital plan and dilution from planned equity issuance. On momentum, HSIC has clearly outperformed over the past year, while NI's data center pipeline represents a longer-dated catalyst that may take years to fully contribute. Risk profiles differ sharply: HSIC carries execution and demand-cycle risk, whereas NI carries regulatory, weather, and balance-sheet leverage risk. I’m watching this closely as the relative performance gap continues to widen.
Tickeron AI Verdict
Based on observable factors — including trend consistency, relative performance, analyst sentiment, and the timing of catalysts — Tickeron's AI would likely favor HSIC over NI in the current environment. HSIC's stronger year-to-date and one-year returns, improving earnings trajectory, and broad "Buy" consensus point to more favorable near-term positioning and trend quality. NI's long-term data center growth story is compelling but is largely back-end loaded and carries financing and regulatory execution uncertainty. As always, this is a probabilistic assessment of current conditions rather than a guarantee of future outcomes.
Using Tickeron’s AI Trading Bots for Deeper Analysis
In my view, incorporating systematic tools can add useful perspective when comparing names like these. Tickeron’s AI Trading Bots allow users to review a range of algorithmic strategies, each with its own performance history and ticker focus, helping align automated signals with individual risk preferences and time horizons.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
HSIC sees its Stochastic Oscillator climbs out of oversold territory
On October 29, 2026, the Stochastic Oscillator for HSIC moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 55 instances where the indicator left the oversold zone. In 32 of the 55 cases the stock moved higher in the following days. This puts the odds of a move higher at over 58%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for HSIC just turned positive on October 13, 2026. Looking at past instances where HSIC's MACD turned positive, the stock continued to rise in 24 of 44 cases over the following month. The odds of a continued upward trend are 55%.
Following a +2.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where HSIC advanced for three days, in 160 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 54%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HSIC as a result. In 64 of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 65%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSIC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 57%.
HSIC broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for HSIC entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. HSIC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 64 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.996) is normal, around the industry mean (12.781). P/E Ratio (24.532) is within average values for comparable stocks, (10.435). Projected Growth (PEG Ratio) (1.715) is also within normal values, averaging (2.016). Dividend Yield (0.000) settles around the average of (0.139) among similar stocks. P/S Ratio (0.750) is also within normal values, averaging (4.260).
The Tickeron Profit vs. Risk Rating rating for this company is 81 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSIC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a distributer of healthcare products and services
Industry MedicalDistributors
Advertisement